FDA Inspection 1106448 — Tomasz Zielinski, MD, PhD
The FDA completed an inspection of Tomasz Zielinski, MD, PhD on September 6, 2019 in Katowice. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Katowice (Poland)
Additional Details
Clinical Investigator (CI)